COO vs. RGEN: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at COO and RGEN, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | COO | RGEN |
|---|---|---|
| Company Name | The Cooper Companies, Inc. | Repligen Corporation |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Life Sciences Tools & Services |
| Market Capitalization | 14.01 billion USD | 8.37 billion USD |
| Exchange | NasdaqGS | NasdaqGS |
| Listing Date | January 21, 1983 | April 29, 1986 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of COO and RGEN by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | COO | RGEN |
|---|---|---|
| 5-Day Price Return | 4.12% | 19.86% |
| 13-Week Price Return | -3.87% | 16.68% |
| 26-Week Price Return | -16.47% | 16.89% |
| 52-Week Price Return | -34.64% | 3.84% |
| Month-to-Date Return | 2.77% | 11.27% |
| Year-to-Date Return | -23.35% | 3.33% |
| 10-Day Avg. Volume | 2.78M | 0.97M |
| 3-Month Avg. Volume | 2.87M | 0.83M |
| 3-Month Volatility | 37.20% | 51.84% |
| Beta | 1.06 | 1.14 |
Profitability
Return on Equity (TTM)
COO
4.97%
Health Care Equipment & Supplies Industry
- Max
- 29.93%
- Q3
- 16.99%
- Median
- 9.28%
- Q1
- 5.10%
- Min
- -12.52%
COO’s Return on Equity of 4.97% is in the lower quartile for the Health Care Equipment & Supplies industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.
RGEN
-0.69%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
RGEN has a negative Return on Equity of -0.69%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
Net Profit Margin (TTM)
COO
10.08%
Health Care Equipment & Supplies Industry
- Max
- 24.41%
- Q3
- 13.71%
- Median
- 10.08%
- Q1
- 5.96%
- Min
- -5.58%
COO’s Net Profit Margin of 10.08% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
RGEN
-2.05%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
RGEN has a negative Net Profit Margin of -2.05%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
Operating Profit Margin (TTM)
COO
18.31%
Health Care Equipment & Supplies Industry
- Max
- 31.09%
- Q3
- 18.11%
- Median
- 15.07%
- Q1
- 8.48%
- Min
- -0.28%
An Operating Profit Margin of 18.31% places COO in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
RGEN
-3.51%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
RGEN has a negative Operating Profit Margin of -3.51%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
Profitability at a Glance
| Symbol | COO | RGEN |
|---|---|---|
| Return on Equity (TTM) | 4.97% | -0.69% |
| Return on Assets (TTM) | 3.31% | -0.48% |
| Net Profit Margin (TTM) | 10.08% | -2.05% |
| Operating Profit Margin (TTM) | 18.31% | -3.51% |
| Gross Profit Margin (TTM) | 66.96% | 50.99% |
Financial Strength
Current Ratio (MRQ)
COO
2.12
Health Care Equipment & Supplies Industry
- Max
- 5.19
- Q3
- 3.00
- Median
- 2.13
- Q1
- 1.44
- Min
- 0.86
COO’s Current Ratio of 2.12 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
RGEN
8.59
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
RGEN’s Current Ratio of 8.59 is exceptionally high, placing it well outside the typical range for the Life Sciences Tools & Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.
Debt-to-Equity Ratio (MRQ)
COO
0.30
Health Care Equipment & Supplies Industry
- Max
- 1.61
- Q3
- 0.76
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
COO’s Debt-to-Equity Ratio of 0.30 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
RGEN
0.26
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
RGEN’s Debt-to-Equity Ratio of 0.26 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
COO
5.87
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 25.56
- Median
- 9.60
- Q1
- 3.78
- Min
- -26.49
COO’s Interest Coverage Ratio of 5.87 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
RGEN
13.28
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
RGEN’s Interest Coverage Ratio of 13.28 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | COO | RGEN |
|---|---|---|
| Current Ratio (MRQ) | 2.12 | 8.59 |
| Quick Ratio (MRQ) | 0.91 | 7.04 |
| Debt-to-Equity Ratio (MRQ) | 0.30 | 0.26 |
| Interest Coverage Ratio (TTM) | 5.87 | 13.28 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
COO
0.00%
Health Care Equipment & Supplies Industry
- Max
- 4.15%
- Q3
- 1.76%
- Median
- 0.79%
- Q1
- 0.00%
- Min
- 0.00%
COO currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
RGEN
0.00%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
RGEN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
COO
2.41%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 66.60%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
COO’s Dividend Payout Ratio of 2.41% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
RGEN
0.00%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
RGEN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | COO | RGEN |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 2.41% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
COO
33.89
Health Care Equipment & Supplies Industry
- Max
- 67.29
- Q3
- 47.01
- Median
- 30.94
- Q1
- 23.91
- Min
- 10.79
COO’s P/E Ratio of 33.89 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
RGEN
--
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
P/E Ratio data for RGEN is currently unavailable.
Price-to-Sales Ratio (TTM)
COO
3.42
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.86
- Q1
- 2.07
- Min
- 0.74
COO’s P/S Ratio of 3.42 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
RGEN
12.43
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
With a P/S Ratio of 12.43, RGEN trades at a valuation that eclipses even the highest in the Life Sciences Tools & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
Price-to-Book Ratio (MRQ)
COO
1.69
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 6.56
- Median
- 3.53
- Q1
- 2.36
- Min
- 0.71
COO’s P/B Ratio of 1.69 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
RGEN
3.39
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
RGEN’s P/B Ratio of 3.39 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | COO | RGEN |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 33.89 | -- |
| Price-to-Sales Ratio (TTM) | 3.42 | 12.43 |
| Price-to-Book Ratio (MRQ) | 1.69 | 3.39 |
| Price-to-Free Cash Flow Ratio (TTM) | 33.55 | 79.07 |